Call Us : +91-22-2610 9281
ip cell

IP Cell

In January 2009, the IPA was gravely concerned about the frequent reports relating to the process of examination and quality of patents in India. It also realized the consequences of inaction, as it would create jurisprudence which, in the long run, could seriously hurt the National Companies and public health.

The IPA, therefore, decided to set-up an IP Cell to examine all patent applications relating to pharmaceuticals and biopharmaceuticals published from 1st January 2009 and those which were published before 31st December 2008 but has not been processed as yet.


To identify applications that may come under the purview of Sections 3(d) and 3(e) of the Patents Act, 1970.
To consider and appoint agencies from academia, universities and profession to screen and shortlist such applications as noted in (a) above.
To examine and initiate pre-grant opposition proceedings against inappropriate applications.
To engage qualified professionals to initiate action as noted in (c) above.
To work towards rejection of inappropriate patent applications.